DK1186295T3 - Farmaceutiske tilberedninger indeholdende ekstrakter af sojaisoflavon og probiotiske mikroorganismer - Google Patents

Farmaceutiske tilberedninger indeholdende ekstrakter af sojaisoflavon og probiotiske mikroorganismer

Info

Publication number
DK1186295T3
DK1186295T3 DK01402270T DK01402270T DK1186295T3 DK 1186295 T3 DK1186295 T3 DK 1186295T3 DK 01402270 T DK01402270 T DK 01402270T DK 01402270 T DK01402270 T DK 01402270T DK 1186295 T3 DK1186295 T3 DK 1186295T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparations
preparations containing
probiotic microorganisms
containing extracts
soy isoflavone
Prior art date
Application number
DK01402270T
Other languages
English (en)
Inventor
Pierre Fabre
Bernard Fabre
Rene Belle
Original Assignee
Plantes Et Medecines
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plantes Et Medecines filed Critical Plantes Et Medecines
Application granted granted Critical
Publication of DK1186295T3 publication Critical patent/DK1186295T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DK01402270T 2000-09-11 2001-08-31 Farmaceutiske tilberedninger indeholdende ekstrakter af sojaisoflavon og probiotiske mikroorganismer DK1186295T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0011515A FR2813790B1 (fr) 2000-09-11 2000-09-11 Preparations pharmaceutiques contenant des extraits d'isoflavone de soja et des micro-organismes probiotiques

Publications (1)

Publication Number Publication Date
DK1186295T3 true DK1186295T3 (da) 2006-10-30

Family

ID=8854136

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01402270T DK1186295T3 (da) 2000-09-11 2001-08-31 Farmaceutiske tilberedninger indeholdende ekstrakter af sojaisoflavon og probiotiske mikroorganismer

Country Status (10)

Country Link
US (1) US20020114786A1 (da)
EP (1) EP1186295B1 (da)
AT (1) ATE333875T1 (da)
CA (1) CA2356466A1 (da)
CY (1) CY1106211T1 (da)
DE (1) DE60121686T2 (da)
DK (1) DK1186295T3 (da)
ES (1) ES2267695T3 (da)
FR (1) FR2813790B1 (da)
PT (1) PT1186295E (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003293977A1 (en) * 2002-10-16 2004-05-04 L'oreal Cosmetic composition for preventing and/or correcting the functional disorders of the pilo-sebaceous unit of mammals
AU2003298659A1 (en) * 2002-11-15 2004-06-15 Cargill, Incorporated Soluble isoflavone compositions
US7025998B2 (en) * 2003-05-30 2006-04-11 Rotta Research Laboratorium S.P.A. Phytoestrogens and probiotic for women's health
US7935334B2 (en) * 2005-07-07 2011-05-03 Imagilin Technologies, LLC Probiotics as alternative medicines against infectious diseases
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
CN102905712B (zh) 2010-01-28 2015-12-16 Ab－生物学有限公司 用于治疗肠炎的益生菌组合物
ITMI20111829A1 (it) * 2011-10-07 2013-04-08 Paladin Pharma S P A Procedimento per la preparazione di una composizione a base di equolo
KR102362968B1 (ko) * 2019-11-25 2022-02-17 주식회사 쎌바이오텍 유산균 및 프리바이오틱스를 포함하는 갱년기 증상의 예방, 완화 또는 치료용 조성물
WO2025181244A1 (en) 2024-02-28 2025-09-04 International N&H Denmark Aps Use of probiotic combinations for alleviating menopausal symptoms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3489930B2 (ja) * 1996-03-08 2004-01-26 株式会社ヤクルト本社 がん予防食品
WO1998021946A1 (en) * 1996-11-18 1998-05-28 Internutria, Inc. Composition and treatment for persistent reproductive transition symptoms
FI107014B (fi) * 1997-07-25 2001-05-31 Oriola Oy Terveysravintovalmiste
CN1184895C (zh) * 1998-07-16 2005-01-19 阿龙·塔博尔 大豆组合物及其促进健康的应用

Also Published As

Publication number Publication date
PT1186295E (pt) 2006-11-30
DE60121686T2 (de) 2007-05-03
ATE333875T1 (de) 2006-08-15
US20020114786A1 (en) 2002-08-22
CA2356466A1 (fr) 2002-03-11
EP1186295A1 (fr) 2002-03-13
ES2267695T3 (es) 2007-03-16
EP1186295B1 (fr) 2006-07-26
CY1106211T1 (el) 2011-06-08
FR2813790B1 (fr) 2004-03-12
FR2813790A1 (fr) 2002-03-15
DE60121686D1 (de) 2006-09-07

Similar Documents

Publication Publication Date Title
ATE340171T1 (de) Piperazinderivate zur behandlung bakterieller infektionen
DE60215951D1 (de) Piperidinderivate als antibakterielle mittel
DK1161157T3 (da) Kosttilskud og fremgangsmåde til kosmetisk behandling på basis af et drueekstrakt rigt på polyphenoler
TR200101481T2 (tr) Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
GB0101577D0 (en) Compounds
DE60115842D1 (de) Ventilanordnung
AU2003231866A8 (en) Herbs and herbal combinations useful for the treatment of microbial infections
DE60225590D1 (de) C-kithemmer zur behandlung von bakteriellen infektionen
IS6521A (is) Aðferð til að hreinsa gerjunarseyði
DK1186295T3 (da) Farmaceutiske tilberedninger indeholdende ekstrakter af sojaisoflavon og probiotiske mikroorganismer
ATE522203T1 (de) Pharmazeutische herstellung zur bindung von acetaldehyd in speichel, magen und dickdarm
ATE336996T1 (de) Verwendung von flavonoid-derivaten zur behandlung von atopischem ekzem
DE60139544D1 (de) Veränderte, fluoreszierende proteine
NO20031860L (no) Kahalalid F
DK1441761T3 (da) Fremgangsmåder til forebyggelse og behandling af flavivirus-infektion hos dyr
DK1146886T3 (da) Sojaekstrakt indeholdende lipider, fremgangsmåde til fremstilling heraf og farmaceutisk og kosmetisk sammensætning
YU68602A (sh) Monoklonska antitela na humani ldl receptor, njihova produkcija i korišćenje
DE60127622D1 (de) Multimedia-Modular-Karte, sowie Gerät zum Betreiben derselben und integriertes Multimediasystem
DK1163231T3 (da) Perfluoralkylamider, deres fremstilling og deres anvendelse inden for diagnostikken
DK1328169T3 (da) Energirigt fuldkostnæringsmiddel eller kosttilskud, fremgangsmåde til fremstilling af det og anvendelse af det
DE502004007696D1 (de) Flavonoid-derivat
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
ATE400285T1 (de) Mischungen von isoflavonen und flavonen
WO2001089558A3 (en) Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
DK1212072T3 (da) Farmaceutisk præparat omfattende eukalyptus- og orangeolie